Skip to main content
Equibles

UBS Group AG

Position in DRTS — Alpha Tau Medical Ltd.

CIK 1610520 ZURICH, V8
Back to DRTS Full portfolio

Position in DRTS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,079,667
+$6,052,784 QoQ
Shares Held
644,910
+125.0% QoQ
Ownership
0.697%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 74 holders
Holding Since
Mar 2022
14 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in DRTS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. DRTS ranks #123 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in DRTS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,079,667 642,263
2026-03-31 $2,026,883 286,688
2025-12-31 $102,464 20,700
2025-09-30 $138,091 30,619
2025-06-30 $103,955 33,319
2025-03-31 $82,877 33,019
2024-12-31 $217 70
2024-09-30 $2,806 1,179
2024-03-31 $109 37
2023-03-31 $3,708 1,292
2022-12-31 $4,916 1,546
2022-06-30 $17,262 1,916
2022-03-31 $10,620 900